Regulon

Regulon: R-3213

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
132.8531915Pr-137Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
8974 ENSG00000072682 P4HA2 O15460
3693 ENSG00000082781 ITGB5 P18084
10961 ENSG00000089248 ERP29 V9HW71
3783 ENSG00000104783 KCNN4 O15554
768 ENSG00000107159 CA9 Q16790
22943 ENSG00000107984 DKK1 O94907
6675 ENSG00000117143 UAP1 Q16222
1453 ENSG00000141551 CSNK1D P48730
8444 ENSG00000143479 DYRK3 O43781
5352 ENSG00000152952 PLOD2 O00469
3141 ENSG00000159267 HLCS P50747
2669 ENSG00000164949 GEM P55040
1200 ENSG00000166340 TPP1 O14773

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
SULTHIAMECA2Small moleculeINHIBITORCarbonic anhydrase inhibitor40
CILENGITIDEITGAVProteinANTAGONISTIntegrin alpha-V/beta-3 antagonist33
SENICAPOCKCNN4Small moleculeBLOCKERIntermediate conductance calcium-activated potassium channel protein 4 blocker30
DKN-01DKK1UnknownINHIBITORDickkopf-related protein 1 inhibitor20
CG250 177LUCA9AntibodyBINDING AGENTCarbonic anhydrase IX binding agent30
GIRENTUXIMABCA9AntibodyOTHERCarbonic anhydrase IX other30
CG250 111INCA9AntibodyBINDING AGENTCarbonic anhydrase IX binding agent30
INTETUMUMABITGAVAntibodyANTAGONISTIntegrin alpha-V/beta-3 antagonist20
BHQ-880DKK1AntibodyINHIBITORDickkopf-related protein 1 inhibitor20
ABITUZUMABITGAVAntibodyINHIBITORIntegrin alpha-V/beta-5 inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-3213

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs
CMF-09254RP1down-regulatesRXRAactivatesR-3213133Drugs (12)
CMF-15046PTENup-regulatesRXRAactivatesR-3213131Drugs (12)
CMF-17131CDH18up-regulatesRXRAactivatesR-3213131Drugs (12)
CMF-24284SMCHD1up-regulatesRXRAactivatesR-3213131Drugs (12)
CMF-25400CENPFup-regulatesRXRAactivatesR-3213132Drugs (12)